Why Incyte's Q1 Loss Isn't As Bad As It Looks
Like most stocks, Incyte (NASDAQ: INCY) plunged during the market crash that began in late February and extended into March. But Incyte has rebounded more strongly than most, with its shares up by a double-digit percentage year to date.
The biotech reported its first-quarter results before the market opened on Tuesday, with some good news and some bad news. Here are the highlights from Incyte's Q1 update.
Image source: Getty Images.
Source Fool.com
